We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$474M
AUM Growth
+$427M
(+909%)
Cap. Flow
+$433M
Cap. Flow
% of AUM
91.18%
Top 10 Holdings %
Top 10 Hldgs %
10.55%
Holding
454
New
296
Increased
64
Reduced
55
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OXLC
Oxford Lane Capital
OXLC
|
+$6.86M |
| 2 |
Barings BDC
BBDC
|
+$6.33M |
| 3 |
Oxford Square Capital
OXSQ
|
+$5.45M |
| 4 |
ECC
Eagle Point Credit Company
ECC
|
+$5.29M |
| 5 |
FS KKR Capital
FSK
|
+$5.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$2.25M |
| 2 |
ACOR
Acorda Therapeutics
ACOR
|
+$644K |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
+$605K |
| 4 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
+$603K |
| 5 |
uniQure
QURE
|
+$374K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.58% |
| 2 | Real Estate | 14.99% |
| 3 | Energy | 13.55% |
| 4 | Healthcare | 12.23% |
| 5 | Materials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Cardinal Health
CAH
$53.4B
| $17K | ﹤0.01% |
358
+115
| +47% | +$5.3K |
|
377
Chipotle Mexican Grill
CMG
$40.8B
| $17K | ﹤0.01% |
+1,150
| New | +$16.2K |
|
378
Monster Beverage
MNST
$91.4B
| $17K | ﹤0.01% |
+534
| New | +$16.1K |
|
379
NVR
NVR
$17.2B
| $17K | ﹤0.01% |
+5
| New | +$16K |
|
380
Reinsurance Group of America
RGA
$15.7B
| $17K | ﹤0.01% |
+111
| New | +$16.6K |
|
381
Franklin Resources
BEN
$16.9B
| $16K | ﹤0.01% |
+468
| New | +$15.9K |
|
382
Northern Trust
NTRS
$22.2B
| $16K | ﹤0.01% |
+177
| New | +$16.3K |
|
383
Pultegroup
PHM
$24.5B
| $16K | ﹤0.01% |
+506
| New | +$15.8K |
|
384
Trip.com Group
TCOM
$27.5B
| $16K | ﹤0.01% |
431
+235
| +120% | +$9.27K |
|
385
Home Depot
HD
$332B
| $15K | ﹤0.01% |
+73
| New | +$14.6K |
|
386
Lear
LEA
$7.19B
| $15K | ﹤0.01% |
+110
| New | +$15.4K |
|
387
Southern Company
SO
$110B
| $15K | ﹤0.01% |
+266
| New | +$14.2K |
|
|
SPLK
388
DELISTED
Splunk Inc
SPLK
| $15K | ﹤0.01% |
+118
| New | +$15K |
|
389
Archer Daniels Midland
ADM
$41.4B
| $14K | ﹤0.01% |
+335
| New | +$13.9K |
|
390
American Financial Group
AFG
$11.9B
| $14K | ﹤0.01% |
+137
| New | +$13.8K |
|
391
Autohome
ATHM
$2.43B
| $14K | ﹤0.01% |
159
+84
| +112% | +$8.37K |
|
392
Freeport-McMoran
FCX
$90B
| $14K | ﹤0.01% |
1,194
| – | – |
|
393
State Street
STT
$50.9B
| $14K | ﹤0.01% |
+256
| New | +$15.9K |
|
394
Seagate
STX
$193B
| $14K | ﹤0.01% |
296
| – | – |
|
|
ATH
395
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $14K | ﹤0.01% |
333
| – | – |
|
396
Consolidated Edison
ED
$41.6B
| $13K | ﹤0.01% |
+147
| New | +$12.7K |
|
397
New Oriental
EDU
$7.84B
| $13K | ﹤0.01% |
+131
| New | +$11.7K |
|
398
Coca-Cola
KO
$354B
| $13K | ﹤0.01% |
+254
| New | +$12.4K |
|
399
Prologis
PLD
$138B
| $13K | ﹤0.01% |
161
| – | – |
|
400
PVH
PVH
$3.71B
| $13K | ﹤0.01% |
+142
| New | +$15.7K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
ALS
Virtus ETF Advisers's Q2 2019 Portfolio in Review
As of Q2 2019, Virtus ETF Advisers held 454 positions worth $474M, up 909% from $47M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Virtus ETF Advisers deployed $433M of net new capital in Q2 2019, opening 296 new positions and adding to 64 existing holdings. Its largest new stake was Oxford Lane Capital: 132,284 shares worth $6.67M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 0.73% a quarter earlier, followed by Real Estate and Energy.
On the sell side, the largest reduction was Array Biopharma Inc, an estimated $605K trimmed.
- Virtus ETF Advisers's largest Q2 2019 buy was Oxford Lane Capital: 132,284 shares worth $6.67M.
- Virtus ETF Advisers added most to Dominion Energy in Q2 2019, an estimated $2.63M increase.
- Virtus ETF Advisers's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $605K.
- Virtus ETF Advisers fully exited Spark Therapeutics, Inc. Common Stock in Q2 2019, selling an estimated $2.25M.
- Virtus ETF Advisers's ten largest holdings make up 11% of its $474M portfolio in Q2 2019.
- Virtus ETF Advisers opened 296 new positions and closed 20 in Q2 2019.
- Virtus ETF Advisers's portfolio value rose 909% quarter-over-quarter to $474M.
Based on Virtus ETF Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.